EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease

Donghee Kim, Pojsakorn Danpanichkul, Do Han Kim, Donghyun Ko, Karn Wijarnpreecha, Aijaz Ahmed

Clinical and Molecular Hepatology · 01.10.2026 · 32 (4) · e2026.0496

DOI: 10.3350/cmh.2026.0496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.10.2026. Verfasst von Donghee Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. dhkimmd90@gmail.com. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular diseaseNon-alcoholic fatty liver diseaseOutcomePREVENT equationsPooled cohort equation

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. dhkimmd90@gmail.com.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and West, New York, NY, USA.
  • Department of Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, AZ, USA.
  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, AZ, USA.

Zitieren

APA

Kim, D., Danpanichkul, P., Kim, D. H., Ko, D., Wijarnpreecha, K., & Ahmed, A. (2026). Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology, 32(4), e2026.0496. https://doi.org/10.3350/cmh.2026.0496

Vancouver

Kim D, Danpanichkul P, Kim DH, Ko D, Wijarnpreecha K, Ahmed A. Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 2026;32(4):e2026.0496. doi:10.3350/cmh.2026.0496

BibTeX
@article{Kim2026,
  author = {Kim, Donghee and Danpanichkul, Pojsakorn and Kim, Do Han and Ko, Donghyun and Wijarnpreecha, Karn and Ahmed, Aijaz},
  title = {Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {e2026.0496},
  doi = {10.3350/cmh.2026.0496}
}
Kostenlos starten →